Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 
> Endothelin-1 (1-31) (Human)

Endothelin-1 (1-31) (Human)

Drucken Drucken
Melden Sie sich an

Katalog-Nummer 4360-s

Size : 0.1mg

Marke : Peptide Institute


Endothelin-1 (1-31) (Human)

Code:
4360-s
Name:
Endothelin-1 (1-31) (Human)
Documents
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 3628.2) C162H236N38O47S5
Purity:
≧95.0% (HPLC)
View Analytical Data Sheet
Storage:
-20 ℃
Production:
Synthetic Product

Solubility: 0.1% AcOH (0.1 mM)

Category:
Biologically Active Peptides

reference

  1. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, J. Immunol., 159, 1987 (1997). (Original; New Endogenous Form)
  2. F. Kishi, K. Minami, N. Okishima, M. Murakami, S. Mori, M. Yano, Y. Niwa, Y. Nakaya, and H. Kido, Biochem. Biophys. Res. Commun., 248, 387 (1998). (Pharmacol.)
  3. M. Yoshizumi, D. Inui, N. Okishima, H. Houchi, K. Tsuchiya, H. Wakabayashi, H. Kido, and T. Tamaki, Eur. J. Pharmacol., 348, 305 (1998). (Pharmacol.)
  4. M. Yoshizumi, S. Kim, S. Kagami, A. Hamaguchi, K. Tsuchiya, H. Houchi, H. Iwao, H. Kido, and T. Tamaki, Br. J. Pharmacol., 125, 1019 (1998). (Pharmacol.)
  5. M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
  6. T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, 103 (1992). (Review)
  7. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)